Morgan D B, Cumberbatch M, Cohn S, Scott D, Gunasuntharam T, Davidson C, Chapman C
Br J Clin Pharmacol. 1980 Aug;10(2):127-33. doi: 10.1111/j.1365-2125.1980.tb01729.x.
1 Four healthy persons and ten patients with heart failure were studied for 5 to 20 days after they started taking digoxin. The sodium content of their erythrocytes increased and there was an equimolar decrease in potassium content. 2 The increase in erythrocyte sodium for a given increase in plasma digoxin during this acute digitalization was less on average and varied more in the patients than in the healthy persons, that is the patients' erythrocytes were less responsive to digoxin. 3 The average erythrocyte sodium was greater in 183 patients who had been taking digoxin for at least 2 months than in 100 healthy persons not taking digoxin but there was no significant correlation between the plasma digoxin concentrations and erythrocyte sodium concentration in the patients. Indeed, there was no apparent change in the erythrocyte sodium in many of the patients taking digoxin. 4 If the erythrocyte sodium concentration is a reliable guide to the tissue effects of digoxin then the results suggest that there is a wide variation in the response to digoxin between patients both during acute digitalization and during chronic treatment with digoxin.
对4名健康人和10名心力衰竭患者在开始服用地高辛后的5至20天进行了研究。他们红细胞中的钠含量增加,钾含量有等摩尔的减少。
在这种急性洋地黄化过程中,对于血浆地高辛给定的增加量,患者红细胞钠的增加平均较少且变化比健康人更大,即患者的红细胞对地高辛的反应较小。
183名服用地高辛至少2个月的患者的平均红细胞钠含量高于100名未服用地高辛的健康人,但患者血浆地高辛浓度与红细胞钠浓度之间无显著相关性。实际上,许多服用地高辛的患者红细胞钠没有明显变化。
如果红细胞钠浓度是地高辛组织效应的可靠指标,那么结果表明,患者在急性洋地黄化期间和地高辛慢性治疗期间对地高辛的反应存在很大差异。